Clinical Trial

Virtual Reality to Reduce Pain and Anxiety During Extracorporeal Shock Wave Lithotripsy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to evaluate the impact of intraprocedural Virtual Reality (VR) as a non-pharmacological intervention for mitigating anxiety and pain during Extracorporeal Shock Wave Lithotripsy (ESWL). The hypothesis is that VR can effectively reduce both pain and anxiety levels in patients by diverting their cognitive focus, potentially leading to a decrease in pharmacological intervention requirements. The primary outcome is pain at energy level 900 during ESWL for the intervention and the control group. The secondary outcomes are as follows: * Type and dose of analgesia * Conductance scores/values * Anxiety levels * Patient satisfaction * Procedure duration * Adverse events Participants will be randomized into either the intervention or control group. Both groups will undergo ESWL according to standard treatment; however, the intervention group will wear a Virtual Reality headset and noise-cancelling headphones during the procedure, while the control group will not
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-24; most recent amendment 2025-09-22.
Status change: Not Yet Recruiting → Recruiting 2025-01-22
Trial Details
NCT Number NCT06616324
Lead Sponsor Zealand University Hospital
Conditions Anxiety, Pain, Virtual Reality, Lithotripsy
Enrollment 72 participants
Start Date 2024-10-24
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-23